FI832927A0 - FRAMEWORK FOR THE PRODUCTION OF PHARMACEUTICAL ACTIVATED TETRAZINDERIVAT - Google Patents

FRAMEWORK FOR THE PRODUCTION OF PHARMACEUTICAL ACTIVATED TETRAZINDERIVAT

Info

Publication number
FI832927A0
FI832927A0 FI832927A FI832927A FI832927A0 FI 832927 A0 FI832927 A0 FI 832927A0 FI 832927 A FI832927 A FI 832927A FI 832927 A FI832927 A FI 832927A FI 832927 A0 FI832927 A0 FI 832927A0
Authority
FI
Finland
Prior art keywords
tetrazinderivat
framework
production
pharmaceutical
activated
Prior art date
Application number
FI832927A
Other languages
Finnish (fi)
Other versions
FI832927A (en
FI80273C (en
FI80273B (en
Inventor
Ghouse Unissa Baig
Malcolm Francis Graham Stevens
Edward Lunt
Christopher Gregory Newton
Brian Leslie Pedgrift
Christopher Smith
Colin Geoffrey Straw
Roger John Aitchison Walsh
Peter James Warren
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB838306904A external-priority patent/GB8306904D0/en
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of FI832927A0 publication Critical patent/FI832927A0/en
Publication of FI832927A publication Critical patent/FI832927A/en
Application granted granted Critical
Publication of FI80273B publication Critical patent/FI80273B/en
Publication of FI80273C publication Critical patent/FI80273C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/88—Nitrogen atoms, e.g. allantoin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C07D233/92—Nitro radicals attached in position 4 or 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
    • C07D487/14—Ortho-condensed systems
FI832927A 1982-08-17 1983-08-15 PROCEDURE FOR FRAMSTATING OF THERAPEUTIC THERAPEUTIC (3H) -IMIDAZO / 5,1-D / -1,2,3,5, -TETRAZIN-4-ON-DERIVAT. FI80273C (en)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
GB8223583 1982-08-17
GB8223583 1982-08-17
GB8223580 1982-08-17
GB8223580 1982-08-17
GB8226169 1982-09-14
GB8226169 1982-09-14
GB838306904A GB8306904D0 (en) 1983-03-14 1983-03-14 Compositions of matter
GB8306904 1983-03-14

Publications (4)

Publication Number Publication Date
FI832927A0 true FI832927A0 (en) 1983-08-15
FI832927A FI832927A (en) 1984-02-18
FI80273B FI80273B (en) 1990-01-31
FI80273C FI80273C (en) 1990-05-10

Family

ID=27449377

Family Applications (1)

Application Number Title Priority Date Filing Date
FI832927A FI80273C (en) 1982-08-17 1983-08-15 PROCEDURE FOR FRAMSTATING OF THERAPEUTIC THERAPEUTIC (3H) -IMIDAZO / 5,1-D / -1,2,3,5, -TETRAZIN-4-ON-DERIVAT.

Country Status (18)

Country Link
AU (1) AU575782B2 (en)
BE (1) BE897548A (en)
CA (1) CA1254563A (en)
CH (1) CH657855A5 (en)
DE (1) DE3329505A1 (en)
DK (1) DK374983A (en)
ES (1) ES8502441A1 (en)
FI (1) FI80273C (en)
FR (1) FR2531958B1 (en)
GR (1) GR78688B (en)
HU (1) HU189321B (en)
IE (1) IE55849B1 (en)
IL (1) IL69500A (en)
IT (1) IT1194375B (en)
LU (1) LU84969A1 (en)
NL (1) NL8302863A (en)
NZ (1) NZ205272A (en)
SE (1) SE455198B (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2932305A1 (en) * 1979-08-09 1981-02-26 Basf Ag Pyrrolo-, pyrazolo-, imidazo- and thiazolo-tetrazin-4-one derivs. - prepd. from amino-azole cpds. by diazotisation and reaction with isocyanate
OA07174A (en) * 1981-08-24 1984-04-30 May & Baker Ltd New imidazotetrazionones, their preparation and medicines containing them.

Also Published As

Publication number Publication date
CH657855A5 (en) 1986-09-30
AU575782B2 (en) 1988-08-11
HU189321B (en) 1986-06-30
ES524995A0 (en) 1985-01-01
FR2531958A1 (en) 1984-02-24
DK374983D0 (en) 1983-08-16
IT8322566A0 (en) 1983-08-16
CA1254563A (en) 1989-05-23
SE455198B (en) 1988-06-27
IL69500A (en) 1989-01-31
GR78688B (en) 1984-09-27
FR2531958B1 (en) 1986-10-31
FI832927A (en) 1984-02-18
FI80273C (en) 1990-05-10
NL8302863A (en) 1984-03-16
ES8502441A1 (en) 1985-01-01
DK374983A (en) 1984-02-18
IT1194375B (en) 1988-09-22
DE3329505A1 (en) 1984-02-23
AU1796883A (en) 1984-02-23
IE55849B1 (en) 1991-01-30
SE8304415L (en) 1984-02-18
BE897548A (en) 1984-02-17
SE8304415D0 (en) 1983-08-15
NZ205272A (en) 1986-12-05
FI80273B (en) 1990-01-31
IE831913L (en) 1984-02-17
LU84969A1 (en) 1984-03-23

Similar Documents

Publication Publication Date Title
FI831740A0 (en) FRAMEWORK FOR THE FRAMEWORK OF ETCES SESKVITERPENLAKTONHALTIGT PHARMACEUTICAL EXTRACT
FI833020A (en) FRAMEWORK FOR FRAMSTAELLNING AV LIMTEJP
FI834057A0 (en) ANORDINATION FOR THE EXTENSION OF MATERIALS
FI813279L (en) FRAMEWORK FOR THE FRAMEWORK OF AZABICYCLO-OCTAN-CARBOLXYLSYROR
FI822748L (en) FRAMEWORK FOR THE SUBSTITUTION OF SUBSTANCES
NO168745C (en) PROCEDURE FOR PREPARING PHARMACEUTICAL MIXTURES
FI822857L (en) FRAMEWORK FOR THE FRAMEWORK OF FRAMSTAELLNING AV EN FAERGKILFOLIE
FI834735A0 (en) FRAMEWORK FOR PHARMACEUTICAL FRAMEWORK ACTIVE PYRIDINDERIVAT
FI812708L (en) PHARMACEUTICAL BLANDING FOR THE FRAMEWORK OF AVAILABILITY
FI813198L (en) FRAMEWORK FOR THE PHARMACOLOGICAL ACTIVITY OF THE PHARMACOLOGICAL PRODUCT
FI832956A (en) FRAMEWORK FOR THE PHARMACOLOGICAL ACTIVITY OF 3-PHENOXY-1-AZETIDINE CARBOXIAMIDER
FI831148L (en) PROCEDURE FOR THE FRAMEWORK OF SUBSTANCES
RO88128A (en) PROCESS FOR THE PREPARATION OF N-PHOSFANOMETILGLICINE
FI831687L (en) PHARMACEUTICAL BLANDNINGAR VILKA INNEHAOLLER FLERE AKTIVA BESTAONDSDELAR
NO841492L (en) PROCEDURE FOR PHARMACEUTICAL ENRICHMENT
FI834736A0 (en) FRAMEWORK FOR PHARMACEUTICAL FRAMEWORK ACTIVE PYRIDINDERIVAT
IS2626A7 (en) Process for the preparation of pharmaceutical compositions
FI800481A (en) FRAMEWORK FOR THE SUBSTANCES OF ACYLPIPERIDINER
FI832927A (en) FRAMEWORK FOR THE PRODUCTION OF PHARMACEUTICAL ACTIVATED TETRAZINDERIVAT
IS1381B6 (en) Process for the production of new dihydropyridines
IT1164613B (en) PROCEDURE FOR THE PRODUCTION OF DITIAZOL-DISULFURI
FI820999L (en) PROCEDURE FOR THE FRAMEWORK OF THE PHARMACEUTICAL SYSTEM
TR21803A (en) PROCEDURE FOR THE PRODUCTION OF ATESE-RESISTANT CHROMMAGNESIA UERUENES
FI811638A0 (en) PROCEDURE FOR THE FRAMEWORK OF HEATEROCYCLES
FI831893L (en) FRAMEWORK FOR THE FRAMEWORK OF THE PHARMACEUTICAL COMPOSITION

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: MAY & BAKER LIMITED